279 related articles for article (PubMed ID: 32849278)
1. Telomerase Reverse Transcriptase (TERT) Regulation in Thyroid Cancer: A Review.
McKelvey BA; Umbricht CB; Zeiger MA
Front Endocrinol (Lausanne); 2020; 11():485. PubMed ID: 32849278
[No Abstract] [Full Text] [Related]
2. Characterization of Allele-Specific Regulation of Telomerase Reverse Transcriptase in Promoter Mutant Thyroid Cancer Cell Lines.
McKelvey BA; Gilpatrick T; Wang Y; Timp W; Umbricht CB; Zeiger MA
Thyroid; 2020 Oct; 30(10):1470-1481. PubMed ID: 32228178
[No Abstract] [Full Text] [Related]
3. Characterization of human telomerase reverse transcriptase promoter methylation and transcription factor binding in differentiated thyroid cancer cell lines.
Avin BA; Wang Y; Gilpatrick T; Workman RE; Lee I; Timp W; Umbricht CB; Zeiger MA
Genes Chromosomes Cancer; 2019 Aug; 58(8):530-540. PubMed ID: 30664813
[TBL] [Abstract][Full Text] [Related]
4. TERT promoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA.
Wang N; Liu T; Sofiadis A; Juhlin CC; Zedenius J; Höög A; Larsson C; Xu D
Cancer; 2014 Oct; 120(19):2965-79. PubMed ID: 24898513
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of TERT Reactivation and Its Interaction with BRAFV600E.
Song YS; Park YJ
Endocrinol Metab (Seoul); 2020 Sep; 35(3):515-525. PubMed ID: 32981294
[TBL] [Abstract][Full Text] [Related]
6. TERT-Regulation and Roles in Cancer Formation.
Dratwa M; Wysoczańska B; Łacina P; Kubik T; Bogunia-Kubik K
Front Immunol; 2020; 11():589929. PubMed ID: 33329574
[TBL] [Abstract][Full Text] [Related]
7. Allele-specific proximal promoter hypomethylation of the telomerase reverse transcriptase gene (TERT) associates with TERT expression in multiple cancers.
Rowland TJ; Bonham AJ; Cech TR
Mol Oncol; 2020 Oct; 14(10):2358-2374. PubMed ID: 33245585
[TBL] [Abstract][Full Text] [Related]
8. Telomerase in differentiated thyroid cancer: promoter mutations, expression and localization.
Muzza M; Colombo C; Rossi S; Tosi D; Cirello V; Perrino M; De Leo S; Magnani E; Pignatti E; Vigo B; Simoni M; Bulfamante G; Vicentini L; Fugazzola L
Mol Cell Endocrinol; 2015 Jan; 399():288-95. PubMed ID: 25448848
[TBL] [Abstract][Full Text] [Related]
9. Genetic and epigenetic background and protein expression profiles in relation to telomerase activation in medullary thyroid carcinoma.
Wang N; Kjellin H; Sofiadis A; Fotouhi O; Juhlin CC; Bäckdahl M; Zedenius J; Xu D; Lehtiö J; Larsson C
Oncotarget; 2016 Apr; 7(16):21332-46. PubMed ID: 26870890
[TBL] [Abstract][Full Text] [Related]
10. Transcriptome analysis of papillary thyroid cancer harboring telomerase reverse transcriptase promoter mutation.
Chien MN; Yang PS; Hsu YC; Liu TP; Lee JJ; Cheng SP
Head Neck; 2018 Nov; 40(11):2528-2537. PubMed ID: 30102829
[TBL] [Abstract][Full Text] [Related]
11. Exploring the epigenetic regulation of telomerase reverse transcriptase (TERT) in human cancer cell lines.
McKelvey BA; Zeiger MA; Umbricht CB
Mol Oncol; 2020 Oct; 14(10):2355-2357. PubMed ID: 32920953
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation of the TERT promoter and its impact on human cancer.
Lee DD; Komosa M; Nunes NM; Tabori U
Curr Opin Genet Dev; 2020 Feb; 60():17-24. PubMed ID: 32114294
[TBL] [Abstract][Full Text] [Related]
13. Telomerase reverse transcriptase mutations are independent predictor of disease-free survival in Middle Eastern papillary thyroid cancer.
Bu R; Siraj AK; Divya SP; Kong Y; Parvathareddy SK; Al-Rasheed M; Al-Obaisi KAS; Victoria IG; Al-Sobhi SS; Al-Dawish M; Al-Dayel F; Al-Kuraya KS
Int J Cancer; 2018 May; 142(10):2028-2039. PubMed ID: 29266240
[TBL] [Abstract][Full Text] [Related]
14. TERT Promoter Methylation Is Oxygen-Sensitive and Regulates Telomerase Activity.
Dogan F; Forsyth NR
Biomolecules; 2024 Jan; 14(1):. PubMed ID: 38275760
[TBL] [Abstract][Full Text] [Related]
15. Human telomerase reverse transcriptase regulation by DNA methylation, transcription factor binding and alternative splicing (Review).
Avin BA; Umbricht CB; Zeiger MA
Int J Oncol; 2016 Dec; 49(6):2199-2205. PubMed ID: 27779655
[TBL] [Abstract][Full Text] [Related]
16. Template activating factor-I epigenetically regulates the TERT transcription in human cancer cells.
Kato K; Kawaguchi A; Nagata K
Sci Rep; 2021 Sep; 11(1):17726. PubMed ID: 34489496
[TBL] [Abstract][Full Text] [Related]
17. Interaction of BRAF-induced ETS factors with mutant TERT promoter in papillary thyroid cancer.
Song YS; Yoo SK; Kim HH; Jung G; Oh AR; Cha JY; Kim SJ; Cho SW; Lee KE; Seo JS; Park YJ
Endocr Relat Cancer; 2019 Jun; 26(6):629-641. PubMed ID: 30999281
[TBL] [Abstract][Full Text] [Related]
18. Telomerase and Telomeres Biology in Thyroid Cancer.
Donati B; Ciarrocchi A
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31200515
[TBL] [Abstract][Full Text] [Related]
19. Mutation of the TERT promoter, switch to active chromatin, and monoallelic TERT expression in multiple cancers.
Stern JL; Theodorescu D; Vogelstein B; Papadopoulos N; Cech TR
Genes Dev; 2015 Nov; 29(21):2219-24. PubMed ID: 26515115
[TBL] [Abstract][Full Text] [Related]
20. CTCF mediates the TERT enhancer-promoter interactions in lung cancer cells: identification of a novel enhancer region involved in the regulation of TERT gene.
Eldholm V; Haugen A; Zienolddiny S
Int J Cancer; 2014 May; 134(10):2305-13. PubMed ID: 24174344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
